Bridion® injection now approved for patients of all ages
Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA
A forum for researchers, students and applicants in the field of cyclodextrin technology
Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA